NLRP3 inflammasome inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 12139471
APP PUB NO 20220251067A1
SERIAL NO

17574820

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to novel pyridazin-3-yl phenol compounds of Formula (I):

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVARTIS AGBASEL

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Farady, Christopher Basel, CH 6 7
Gommermann, Nina Lörrach, DE 4 7
Janser, Philipp Basel, CH 12 37
Mackay, Angela Basel, CH 5 12
Mattes, Henri Michelbach le Bas, FR 19 104
Smith, Nichola Burlington, US 28 72
Solovay, Catherine Fooks Arlington, US 8 16
Stiefl, Nikolaus Johannes Lörrach, DE 17 102
Vangrevelinghe, Eric Saint-Louis, FR 10 17
Velcicky, Juraj Basel, CH 7 19
von, Matt Anette Biel-Benken, CH 23 256

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 May 12, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 May 12, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 12, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00